Approval · Notice of Compliance 8183 · 2006
NEXAVAR: Notice of Compliance 8183
Issued July 28, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8183
- Date
- July 28, 2006
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Multikinase inhibitor / antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXAVAR | 02284227 | Marketed |
Medicinal ingredients
- SORAFENIB 200 MG per TAB